KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Other Non-Current Liabilities (2016 - 2025)

Edwards Lifesciences has reported Other Non-Current Liabilities over the past 17 years, most recently at $502.7 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $502.7 million for Q4 2025, up 34.66% from a year ago — trailing twelve months through Dec 2025 was $502.7 million (up 34.66% YoY), and the annual figure for FY2025 was $502.7 million, up 34.66%.
  • Other Non-Current Liabilities for Q4 2025 was $502.7 million at Edwards Lifesciences, up from $362.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for EW hit a ceiling of $502.7 million in Q4 2025 and a floor of $25.7 million in Q3 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $293.0 million (2022), compared with a mean of $268.3 million.
  • Peak annual rise in Other Non-Current Liabilities hit 257.47% in 2022, while the deepest fall reached 90.2% in 2022.
  • Edwards Lifesciences' Other Non-Current Liabilities stood at $267.3 million in 2021, then plummeted by 90.2% to $26.2 million in 2022, then soared by 1059.16% to $303.7 million in 2023, then increased by 22.92% to $373.3 million in 2024, then soared by 34.66% to $502.7 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $502.7 million (Q4 2025), $362.6 million (Q3 2025), and $421.6 million (Q2 2025) per Business Quant data.